Highlights:

-Physicians for Integrity in Medical Research says in its federal complaint against Food and Drug Administration Commissioner Margaret Hamburg

– best-case scenario showed that roflumilast reduced the number of exacerbations by one episode a year for every five patients treated

– the regulator ignored the “statistically significant increase in incidents of prostate and lung cancer in patients taking roflumilast.”

———- Possible safe Option Vinpocetine

-Published today in the Proceedings of the National Academy of Sciences vinpocetine has great potential for the treatment of COPD and other inflammatory diseases.”

-has no evidence of toxicity or noticeable side effects in human patients

Links: http://healthresearchreport.me/2014/02/04/doctors-group-sues-fda-saying-drug-does-more-harm-than-good/ http://healthresearchreport.me/2012/11/20/purple-periwinkles-battle-inflammatory-diseases-copd/

Categories: Corruption - Fabricated Data, Ineffective Treatments

Tags: Chronic obstructive pulmonary disease, Commissioner, COPD, Food and Drug Administration, Lung cancer, Margaret Hamburg, Medical research, Roflumilast